Gelatin Hydrogel enhances the engraftment of transplanted Cardiomyocytes and angiogenesis to ameliorate cardiac function after myocardial infarction

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Nakajima, Kazuaki ^a   Fujita, Jun ^a   Matsui, Makoto ^b   Tohyama, Shugo ^a,d   Tamura, Noriko ^c   Kanazawa, Hideaki ^a   Seki, Tomohisa ^a   Kishino, Yoshikazu ^a   Hirano, Akinori ^a   Okada, Marina ^a   Tabei, Ryota ^a   Sano, Motoaki ^a   Goto, Shinya ^c   Tabata, Yasuhiko ^b   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CYTOKINE; GELATIN; SCATTER FACTOR; VASCULOTROPIN; HYDROGEL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ENGRAFTMENT; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HISTOPATHOLOGY; HYDROGEL; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOGENICITY; ANIMAL; CARDIAC MUSCLE CELL; CELL ADHESION; DRUG EFFECTS; HEART FUNCTION TEST; LEWIS RAT; METABOLISM; MYOCARDIAL INFARCTION; NUDE RAT; PATHOLOGY; PATHOPHYSIOLOGY; PHARMACOLOGY; THERAPEUTIC USE; THROMBOSIS; TRANSPLANTATION;

ANIMALS; CELL ADHESION; CYTOKINES; FEMALE; GELATIN; HEART FUNCTION TESTS; HYDROGEL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS, INBRED LEW; RATS, NUDE; THROMBOSIS;

EID: 84941285518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133308     Document Type: Article

References (27)

1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011; 8(1):30-41. Epub 2010/11/10. doi: 10.1038/nrcardio.2010.165
2. Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report-2013; focus theme: Age. J Heart Lung Transplant. 2013; 32(10):951-64. doi: 10.1016/j.healun.2013.08.006
3. Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet. 2012; 379(9819):933-42. Epub 2012/03/13. doi: 10.1016/S0140-6736(12)60075-0
4. Strauer B-E, Steinhoff G. 10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the Heart: From the Methodological Origin to Clinical Practice. J Am Coll Cardiol. 2011; 58 (11):1095-104. doi: 10.1016/j.jacc.2011.06.016
5. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. Circulation. 2008; 117(9):1189-200. doi: 10.1161/circulationaha.107.734103
6. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet. 2012; 379(9819):895-904. Epub 2012/02/18. doi: 10.1016/S0140-6736(12)60195-0
7. Fujita J, Itabashi Y, Seki T, Tohyama S, Tamura Y, Sano M, et al. Myocardial cell sheet therapy and cardiac function. Am J Physiol Heart Circ Physiol. 2012; 303(10):H1169-82. doi: 10.1152/ajpheart.00376.2012
8. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001; 108(3):407-14. doi: 10.1172/JCI12131
9. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009; 104(4):e30-41. Epub 2009/02/14. doi: 10.1161/CIRCRESAHA.108.192237
10. Hemmi N Tohyama S Nakajima K Kanazawa H Suzuki T Hattori F, et al. A Massive Suspension Culture System With Metabolic Purification for Human Pluripotent Stem Cell-Derived Cardiomyocytes. Stem cells translational medicine. 2014. doi: 10.5966/sctm.2014-0072
11. Hattan N, Kawaguchi H, Ando K, Kuwabara E, Fujita J, Murata M, et al. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res. 2005; 65(2):334-44. doi: 10.1016/j.cardiores.2004.10.004
12. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007; 1(1):9-24. Epub 2007/10/01. doi: 10.1016/j.scr.2007.06.001
13. Rane AA, Christman KL. Biomaterials for the treatment of myocardial infarction a 5-year update. J Am Coll Cardiol. 2011; 58(25):2615-29. Epub 2011/12/14. doi: 10.1016/j.jacc.2011.11.001
14. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol. 2006; 48(5):907-13. Epub 2006/09/05. doi: 10.1016/j.jacc.2006.06.005
15. Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, et al. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials. 1998; 19(7-9):807-15.
16. Hato N, Nota J, Komobuchi H, Teraoka M, Yamada H, Gyo K, et al. Facial nerve decompression surgery using bFGF-impregnated biodegradable gelatin hydrogel in patients with Bell palsy. Otolaryngol Head Neck Surg. 2012; 146(4):641-6. doi: 10.1177/0194599811431661
17. Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, et al. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: An initial report of the phase I-IIa study. Circ J. 2007; 71 (8):1181-6.
18. Tabata Y. Biomaterial technology for tissue engineering applications. J R Soc Interface. 2009; 6 Suppl 3:S311-24. doi: 10.1098/rsif.2008.0448.focus
19. Goto S, Tamura N, Handa S, Arai M, Kodama K, Takayama H. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation. 2002; 106(2):266-72.
20. Hayashi K, Tabata Y. Preparation of stem cell aggregates with gelatin microspheres to enhance biological functions. Acta Biomater. 2011; 7(7):2797-803. doi: 10.1016/j.actbio.2011.04.013
21. Olivetti G, Cigola E, Maestri R, Corradi D, Lagrasta C, Gambert SR, et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol. 1996; 28(7):1463-77. Epub 1996/07/01. doi: 10.1006/jmcc.1996.0137
22. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A. 2001; 98(10):5780-5. doi: 10.1073/pnas.091415198
23. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, et al. Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev. 2007; 12(3-4):267-77. doi: 10.1007/s10741-007-9027-0
24. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, et al. Salvage of infracted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992; 257(5075):1401-3.
25. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation. 1997; 95(11):2552-8.
26. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation. 1998; 97(4):381-90.
27. Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 1999; 20(22):2169-75.